Regencell Bioscience
16 hedge funds and large institutions have $9.79M invested in Regencell Bioscience in 2025 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 4 increasing their positions, 5 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
20% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 5
24% less call options, than puts
Call options by funds: $1.26M | Put options by funds: $1.66M
Holders
16
Holding in Top 10
–
Calls
$1.26M
Puts
$1.66M
Top Buyers
| 1 | +$713K | |
| 2 | +$598K | |
| 3 | +$447K | |
| 4 |
VA
Vident Advisory
Alpharetta,
Georgia
|
+$279K |
| 5 |
Jane Street
New York
|
+$164K |
Top Sellers
| 1 | -$888K | |
| 2 | -$751K | |
| 3 | -$624K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$574K |
| 5 |
YIH
Y-Intercept (HK)
Hong Kong
|
-$222K |
